USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
22 Jun 2021 | 02:30 PM GMT

RPM Evidence & Outcomes in Respiratory Diseases

Anchored by:

Abhishek Shah
Co-Founder & CEO
WELLTHY THERAPEUTICS PVT. LTD.
Jyotsna Mehta
CEO
KEVAHEALTH

Participants:

Abhishek Shah Co-Founder & CEOWellthy Therapeutics Pvt. Ltd.
Abhishek Shah
Co-Founder & CEOWellthy Therapeutics Pvt. Ltd.
Jyotsna Mehta CEOKevaHealth
Jyotsna Mehta
CEOKevaHealth
Caleb Bank Senior Product ManagerNuvoAir
Caleb Bank
Senior Product ManagerNuvoAir
Cara Collins Global Director of MarketingVapotherm
Cara Collins
Global Director of MarketingVapotherm
DS
Dan Secor InvestorGilde Healthcare
DS
Dan Secor
InvestorGilde Healthcare
Don Deyo Chief Executive OfficerLindaCare
Don Deyo
Chief Executive OfficerLindaCare
DM
Dr. Ming Jack Po CEOAnsible Health
DM
Dr. Ming Jack Po
CEOAnsible Health
JM
john mattison CMIOACP
JM
john mattison
CMIOACP
Rick Bartels President/Founder DTxCC
Rick Bartels
President/Founder DTxCC
Sean Cheng PartnerPhilips Ventures
Sean Cheng
PartnerPhilips Ventures
SW
Susan Wood CEOVida Diagnostics
SW
Susan Wood
CEOVida Diagnostics
Tim Ruckh Digital Health Clinical Data Collection LeadAstraZeneca
Tim Ruckh
Digital Health Clinical Data Collection LeadAstraZeneca

About this Meeting

Chronic Respiratory Diseases such as COPD and asthma are highly prevalent and lead to a large number of deaths every year. Some of these patients suffer unexpected exacerbations that compromise their health and increase healthcare costs. Remote Patient Monitoring (RPM) has been shown to be helpful for the prevention of COPD and asthma exacerbations as well as in the management of these conditions by recording medication use, coughing patterns, SpO2, FVC (forced vital capacity), FEC1 (forced expiratory volume in 1 second), etc.. Beyond better health outcomes for the patient, some studies have also proven these tools can reduce costs for health systems and payers (fewer hospitalizations, ER visits and readmissions) thus making a strong business case for these products too. If you are a healthcare provider, payer, digital health company, pharma or medtech, join us in this informal discussion on RPM for Chronic Respiratory Diseases where we will talk about:  

  •  Economic outcomes: how health systems and payers can leverage RPM solutions for prevention and management to ultimately reduce healthcare costs.
  •  Clinical outcomes: RPM solutions improving clinical outcomes.